Validations: Ongoing Verification, Trending & CAPA
Trending Tools: Control Charts and EWMA for Low-Level Signals Trending Tools: Control Charts and EWMA for Low-Level Signals In the evolving landscape of pharmaceutical manufacturing and safety, organizations are increasingly challenged with the verification of nitrosamine risks and adherence to guidelines like ICH M7. Ensuring compliance with regulatory bodies such as the US FDA, EMA, and MHRA necessitates the development…
False Positives/Negatives: How to Detect and Handle False Positives/Negatives: How to Detect and Handle In the pharmaceutical industry, the detection and management of nitrosamines, specifically N-Nitrosodimethylamine (NDMA), have become critical due to their potential risks to patient safety. This article offers a comprehensive tutorial on how to effectively handle false positives and negatives when assessing nitrosamine contamination. We will address…
Linking Signals to CAPA: Root-Cause and Effectiveness Checks In the pharmaceutical industry, effective risk management and quality assurance practices are critical to ensuring patient safety. The identification and control of potential impurities, including nitrosamines, have become a significant focus in compliance with FDA, EMA, and PIC/S regulations. This step-by-step tutorial provides a comprehensive guide for pharmaceutical professionals on the processes…
Multi-Site Trending: Standardization and Outlier Detection Multi-Site Trending: Standardization and Outlier Detection Introduction to Multi-Site Trending in Pharmaceutical Validation The pharmaceutical industry faces increasing scrutiny regarding nitrosamine contamination due to stringent regulations from bodies such as the FDA, EMA, and MHRA. Given this context, multi-site trending is a crucial aspect of verification in nitrosamine risk assessment. This article serves as…
Ongoing Verification Plan for Nitrosamines: What to Trend The increasing scrutiny on nitrosamines has prompted pharmaceutical companies to re-evaluate their risk assessment and ongoing verification strategies. As regulatory bodies such as the FDA, EMA, and MHRA continue to emphasize the importance of nitrosamine risk management, it is essential for professionals in the pharmaceutical industry to understand the necessary steps for…